Literature DB >> 9590423

Eosinophil activation in ulcerative colitis: studies on mucosal release and localization of eosinophil granule constituents.

Y Raab1, K Fredens, B Gerdin, R Hällgren.   

Abstract

Activation of eosinophil granulocytes (eosinophils) seems to contribute to the pathophysiology of several inflammatory conditions. This process was evaluated in 18 patients with ulcerative colitis and in 18 healthy controls using intraluminal segmental perfusion of the sigmoid colon and rectum and immunoanalysis for eosinophil cationic protein (ECP) in the perfusate. Immunohistochemistry for eosinophils and neutrophils was made in simultaneously taken biopsies and in biopsies from surgical specimens taken from additional 10 patients. The mucosal release of ECP was increased severalfold in patients with UC. The bowel biopsies demonstrated a lamina propria infiltrated with eosinophils. The degree of eosinophil activation/degranulation was related to the intensity of the inflammatory reaction. Activated eosinophils and extracellular deposits of ECP were, in particular, seen in crypt abscesses and in areas with damaged surface epithelium. Since ECP is highly cytotoxic, its release at the site of inflammatory bowel lesions might reflect a potential pathophysiological mechanism.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9590423     DOI: 10.1023/a:1018843104511

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  31 in total

1.  Increased activation of isolated intestinal lamina propria mononuclear cells in inflammatory bowel disease.

Authors:  S Schreiber; R P MacDermott; A Raedler; R Pinnau; M J Bertovich; G S Nash
Journal:  Gastroenterology       Date:  1991-10       Impact factor: 22.682

2.  Activated eosinophils in chronic inflammatory bowel disease.

Authors:  M Y Choy; J A Walker-Smith; C B Williams; T T MacDonald
Journal:  Lancet       Date:  1990-07-14       Impact factor: 79.321

3.  Mechanism of membrane damage mediated by human eosinophil cationic protein.

Authors:  J D Young; C G Peterson; P Venge; Z A Cohn
Journal:  Nature       Date:  1986 Jun 5-11       Impact factor: 49.962

Review 4.  The eosinophilic leukocyte: structure and function.

Authors:  G J Gleich; C R Adolphson
Journal:  Adv Immunol       Date:  1986       Impact factor: 3.543

5.  Cytotoxic properties of the eosinophil major basic protein.

Authors:  G J Gleich; E Frigas; D A Loegering; D L Wassom; D Steinmuller
Journal:  J Immunol       Date:  1979-12       Impact factor: 5.422

6.  Neutrophil and eosinophil involvement of the small bowel in patients with celiac disease and Crohn's disease: studies on the secretion rate and immunohistochemical localization of granulocyte granule constituents.

Authors:  R Hällgren; J F Colombel; R Dahl; K Fredens; A Kruse; N O Jacobsen; P Venge; J C Rambaud
Journal:  Am J Med       Date:  1989-01       Impact factor: 4.965

7.  Activated eosinophil infiltration and deposits of eosinophil cationic protein in renal allograft rejection.

Authors:  R Hällgren; S O Bohman; K Fredens
Journal:  Nephron       Date:  1991       Impact factor: 2.847

8.  Activated eosinophils evoke chloride secretion in model intestinal epithelia primarily via regulated release of 5'-AMP.

Authors:  M B Resnick; S P Colgan; T W Patapoff; R J Mrsny; C S Awtrey; C Delp-Archer; P F Weller; J L Madara
Journal:  J Immunol       Date:  1993-11-15       Impact factor: 5.422

9.  Eosinophils of human colonic mucosa: C3b and Fc gamma receptor expression and phagocytic capabilities.

Authors:  W L Beeken; I Northwood; C Beliveau; G Baigent; D Gump
Journal:  Clin Immunol Immunopathol       Date:  1987-06

10.  Histaminase release from human granulocytes.

Authors:  R S Zeiger; F J Twarog; H R Colten
Journal:  J Exp Med       Date:  1976-10-01       Impact factor: 14.307

View more
  25 in total

1.  Eosinophil granule-derived major basic protein induces IL-8 expression in human intestinal myofibroblasts.

Authors:  G T Furuta; S J Ackerman; J Varga; A M Spiess; M Y Wang; B K Wershil
Journal:  Clin Exp Immunol       Date:  2000-10       Impact factor: 4.330

2.  Effects of sulfasalazine on biopsy mucosal pathologies and histological grading of patients with active ulcerative colitis.

Authors:  Ying-Qiang Zhong; Hua-Rong Huang; Zhao-Hua Zhu; Qi-Kui Chen; Jun Zhan; Lian-Chun Xing
Journal:  World J Gastroenterol       Date:  2005-07-28       Impact factor: 5.742

3.  Colonic eosinophilic inflammation in experimental colitis is mediated by Ly6C(high) CCR2(+) inflammatory monocyte/macrophage-derived CCL11.

Authors:  Amanda Waddell; Richard Ahrens; Kris Steinbrecher; Burke Donovan; Marc E Rothenberg; Ariel Munitz; Simon P Hogan
Journal:  J Immunol       Date:  2011-04-15       Impact factor: 5.422

4.  CD14+CD33+ myeloid cell-CCL11-eosinophil signature in ulcerative colitis.

Authors:  Maria Lampinen; Amanda Waddell; Richard Ahrens; Marie Carlson; Simon P Hogan
Journal:  J Leukoc Biol       Date:  2013-07-31       Impact factor: 4.962

5.  Evaluation of mucosal eosinophils in the pediatric colon.

Authors:  Licia Pensabene; Marie-Anne Brundler; Juliane M Bank; Carlo Di Lorenzo
Journal:  Dig Dis Sci       Date:  2005-02       Impact factor: 3.199

6.  Fecal markers of inflammation used as surrogate markers for treatment outcome in relapsing inflammatory bowel disease.

Authors:  Michael Wagner; Christer G B Peterson; Peter Ridefelt; Per Sangfelt; Marie Carlson
Journal:  World J Gastroenterol       Date:  2008-09-28       Impact factor: 5.742

7.  Intestinal macrophage/epithelial cell-derived CCL11/eotaxin-1 mediates eosinophil recruitment and function in pediatric ulcerative colitis.

Authors:  Richard Ahrens; Amanda Waddell; Luqman Seidu; Carine Blanchard; Rebecca Carey; Elizabeth Forbes; Maria Lampinen; Tara Wilson; Elizabeth Cohen; Keith Stringer; Edgar Ballard; Ariel Munitz; Huan Xu; Nancy Lee; James J Lee; Marc E Rothenberg; Lee Denson; Simon P Hogan
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

8.  Danger signals derived from stressed and necrotic epithelial cells activate human eosinophils.

Authors:  Anna-Lena Stenfeldt; Christine Wennerås
Journal:  Immunology       Date:  2004-08       Impact factor: 7.397

9.  Heightened Immune Activation in Fetuses with Gastroschisis May Be Blocked by Targeting IL-5.

Authors:  Michela Frascoli; Cerine Jeanty; Shannon Fleck; Patriss W Moradi; Sheila Keating; Aras N Mattis; Qizhi Tang; Tippi C MacKenzie
Journal:  J Immunol       Date:  2016-05-13       Impact factor: 5.422

10.  Serologic investigations in children with inflammatory bowel disease and food allergy.

Authors:  Urszula Grzybowska-Chlebowczyk; Halina Woś; Aleksander L Sieroń; Sabina Wiecek; Aleksandra Auguściak-Duma; Halina Koryciak-Komarska; Joanna Kasznia-Kocot
Journal:  Mediators Inflamm       Date:  2009-12-06       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.